π¬ Current Disease Focus:
Task Progress: 0%
π₯ Active Problem Solvers
0
π Experts collaborating globally
β‘ Current Task Assignment
𧬠Genetic Analysis
π Matching experts to specific tasks
π Resource Allocation by Research Phase:
π Data Analysis
π§ͺ Experimental Design
π¬ Clinical Trials
π Treatment Development
The purpose of this phase II clinical study is to test the good and bad eff...
Status
Completed
Location
Memorial Sloan Kettering Monmouth
Start Date
2016-06-21
Trial ID
NCT02819843
Treatments Being Tested
Evaluation of the mechanism of Action of talimogene laherparepvec (T-VEC) i...
Status
Completed
Location
Department of Dermatology, University Hospital Zurich
Start Date
2018-04-19
Trial ID
NCT03458117
Treatments Being Tested
This phase Ib trials studies the side effects and how well talimogene laher...
Status
Completed
Location
University of California, San Francisco
Start Date
2020-02-05
Trial ID
NCT03554044
The primary objective was to estimate the proportion of participants with d...
Status
Completed
Location
Research Site
Start Date
2014-04-07
Trial ID
NCT02014441
Treatments Being Tested
This study is designed to establish the foundation for a new therapy for ne...
Status
Recruiting
Location
Johns Hopkins University
Start Date
2026-02-01
Trial ID
NCT07102394
Treatments Being Tested
This study is being conducted to learn about the safety and risks of using ...
Status
Terminated
Location
Investigative Clinical Research of Indiana
Start Date
2011-02
Trial ID
NCT01161498
Treatments Being Tested
Kaposi Sarcoma (KS) is a lymphangioproliferation associated with human herp...
Status
Unknown
Location
Service de Dermatologie Hopital Saint-Louis
Start Date
2021-01-01
Trial ID
NCT04065152
Treatments Being Tested
The primary objective of this open-label, Phase I, trial is to evaluate the...
Status
Completed
Location
University of Illinois College of Medicine at Chicago
Start Date
2019-05-23
Trial ID
NCT03663712
Treatments Being Tested
The purpose of this research study is to determine the safety and tolerabil...
Status
Completed
Location
University of Iowa Hospitals and Clinics
Start Date
2015-07-13
Trial ID
NCT02453191
Treatments Being Tested
This phase II trial studies how well talimogene laherparepvec and nivolumab...
Status
Active Not Recruiting
Location
Los Angeles General Medical Center
Start Date
2017-09-27
Trial ID
NCT02978625